Kedrion Biopharma

Kedrion Biopharma is a global biopharmaceutical company specializing in the collection and fractionation of human plasma to produce and distribute plasma-derived therapeutic products. The company focuses on treating rare, ultra-rare, and debilitating conditions, including immunodeficiencies, coagulation disorders, and Rh sensitization. Headquartered in Italy, Kedrion operates a vertically integrated model, managing its own plasma collection centers (KEDPLASMA) and manufacturing facilities across multiple countries. The company is committed to scientific innovation, sustainable plasma processing, and expanding access to life-saving therapies globally, with a significant strategic focus on the U.S. market.